Oral Presentation 50 Years Shine-Dalgarno Symposium 2023

Harnessing mRNA to engineer immune cells for cancer immunotherapy (#14)

Daniel Getts 1
  1. Myeloid Therapeutics Inc, Cambridge, USA, United States

Abstract unavailable